Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review

Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review

Pulmonary giant cell carcinoma (PGCC) is a rare subtype of non-small cell lung cancer (NSCLC) characterized by complex pathology, high rates of misdiagnosis or missed diagnosis, an aggressive clinical course, rapid progression, and poor prognosis. This case report describes a 67-year-old Chinese mal...

Full description

Saved in:
Bibliographic Details
Main Authors: Minghong Xie, Yunlong Zhao, Xiaohua Hou, Ning Li, Sha Niu, Xinju Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
pulmonary giant cell carcinoma
Penpulimab injection
Anlotinib
cerebral metastases
PD-L1 positivity
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1476205/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1476205/full

Similar Items